Microfluidics and cancer: are we there yet?
- 2.4k Downloads
More than two decades ago, microfluidics began to show its impact in biological research. Since then, the field of microfluidics has evolving rapidly. Cancer is one of the leading causes of death worldwide. Microfluidics holds great promise in cancer diagnosis and also serves as an emerging tool for understanding cancer biology. Microfluidics can be valuable for cancer investigation due to its high sensitivity, high throughput, less material-consumption, low cost, and enhanced spatio-temporal control. The physical laws on microscale offer an advantage enabling the control of physics, biology, chemistry and physiology at cellular level. Furthermore, microfluidic based platforms are portable and can be easily designed for point-of-care diagnostics. Developing and applying the state of the art microfluidic technologies to address the unmet challenges in cancer can expand the horizons of not only fundamental biology but also the management of disease and patient care. Despite the various microfluidic technologies available in the field, few have been tested clinically, which can be attributed to the various challenges existing in bridging the gap between the emerging technology and real world applications. We present a review of role of microlfuidcs in cancer research, including the history, recent advances and future directions to explore where the field stand currently in addressing complex clinical challenges and future of it. This review identifies four critical areas in cancer research, in which microfluidics can change the current paradigm. These include cancer cell isolation, molecular diagnostics, tumor biology and high-throughput screening for therapeutics. In addition, some of our lab’s current research is presented in the corresponding sections.
KeywordsMicrofluidics Cancer Cancer diagnostics Circulating tumor cells Tumor biology Bio MEMS Cancer therapeutics
This work was supported by the NIH Director’s New Innovator Award 1DP2 OD006672-01, and 3M Non tenured faculty award to Prof. Nagrath. The work was performed in part at the Lurie Nanofabrication Facility, a member of the National Nanotechnology Infrastructure Network, which is supported by the National Science Foundation.
- Y. Huang et al., Evaluation of cancer stem cell migration using compartmentalizing microfluidic devices and live cell imaging. J. Visual. Exp. 58 (2011)Google Scholar
- J.H. Kang et al., A combined micromagnetic-microfluidic device for rapid capture and culture of rare circulating tumor cells. Lab Chip (2012a)Google Scholar
- J. Kim et al., A programmable microfluidic cell array for combinatorial drug screening. Lab Chip (2012)Google Scholar
- H. Mohamed, M. Murray, J.N. Turner, M. Caggana, Circulating tumor cells: captured with a micromachined device. NSTI-Nanotech 1 (2005)Google Scholar
- D.D. Taylor, C. Gerçel-Taylor, Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects. Br. J. Cancer 92(2), 305–311 (2005)Google Scholar
- R. Weinberg, The Biology of Cancer (Garland Science, New York, 2006)Google Scholar